306 related articles for article (PubMed ID: 10471348)
41. The St. Thomas' hospital cardioplegic solution: a characterization in two species.
Jynge P; Hearse DJ; Feuvray D; Mahalu W; Canković-Darracott S; O'Brien K; Braimbridge MV
Scand J Thorac Cardiovasc Surg Suppl; 1981; 30():1-28. PubMed ID: 6278581
[TBL] [Abstract][Full Text] [Related]
42. Protection of the ischemic myocardium: cold chemical cardioplegia, coronary infustates and the importance of cellular calcium control.
Jynge P
Thorac Cardiovasc Surg; 1980 Oct; 28(5):310-21. PubMed ID: 6161429
[TBL] [Abstract][Full Text] [Related]
43. The effects of Na movement on surgical myocardial protection: the role of the Na+-H+ exchange system and Na-channel in the development of ischemia and reperfusion injury.
Liu KX; Yamamoto F; Yamamoto H; Wang T; Zhu Z; Xu R; Zhang S
Ann Thorac Cardiovasc Surg; 2007 Oct; 13(5):301-7. PubMed ID: 17954986
[TBL] [Abstract][Full Text] [Related]
44. Experimental study on the scavenging effects of ginsenosides on oxygen free radicals using model of heterotopic heart transplantation in rats.
Liu K; Abe T; Sekine S; Goto Y; Iijima K; Kondon K; Matsukawa M; Tian J; Wu W; Zhang B; Chen L; Zhang H; Zhang X; Zhao H; Song X
Ann Thorac Cardiovasc Surg; 1998 Aug; 4(4):188-91. PubMed ID: 9738118
[TBL] [Abstract][Full Text] [Related]
45. The protective effect of lisinopril on membrane-bound enzymes in myocardial preservation.
Selim Isbir C; Doğan R; Farsak B; Aydin M; Kilinç K
Cell Biochem Funct; 2000 Jun; 18(2):85-91. PubMed ID: 10814965
[TBL] [Abstract][Full Text] [Related]
46. [Oxygenation of St. Thomas' Hospital cardioplegic solutions--effects of myocardial temperature and carbon dioxide].
Mukaeyama Y; Yamamoto S
Nihon Kyobu Geka Gakkai Zasshi; 1991 Feb; 39(2):133-43. PubMed ID: 2033329
[TBL] [Abstract][Full Text] [Related]
47. Cardioplegia and vascular injury. Dissociation of the effects of ischemia from those of the cardioplegic solution.
Saldanha C; Hearse DJ
J Thorac Cardiovasc Surg; 1994 Aug; 108(2):279-90. PubMed ID: 8041176
[TBL] [Abstract][Full Text] [Related]
48. Developmental differences in myocardial protection in response to 5'-nucleotidase inhibition.
Pridjian AK; Bove EL; Bolling SF; Childs KF; Brosamer KM; Lupinetti FM
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):520-6. PubMed ID: 8302072
[TBL] [Abstract][Full Text] [Related]
49. K(ATP) channel opener protects neonatal rabbit heart better than St. Thomas' solution.
Feng J; Li H; Rosenkranz ER
J Surg Res; 2003 Feb; 109(2):69-73. PubMed ID: 12643846
[TBL] [Abstract][Full Text] [Related]
50. St Thomas' Hospital polarizing blood cardioplegia improves hemodynamic recovery in a porcine model of cardiopulmonary bypass.
Santer D; Kramer A; Kiss A; Aumayr K; Hackl M; Heber S; Chambers DJ; Hallström S; Podesser BK
J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1543-1554.e8. PubMed ID: 31753163
[TBL] [Abstract][Full Text] [Related]
51. [Efficacy of crystalloid cardioplegia against immature myocardium].
Aeba R
Nihon Kyobu Geka Gakkai Zasshi; 1989 Jun; 37(6):1131-42. PubMed ID: 2809286
[TBL] [Abstract][Full Text] [Related]
52. [Effects of oxygenation and/or SOD on addition to St. Thomas' Hospital cardioplegic solution].
Kihana E
Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar; 41(3):347-55. PubMed ID: 8478561
[TBL] [Abstract][Full Text] [Related]
53. Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2002 Aug; 124(2):340-51. PubMed ID: 12167795
[TBL] [Abstract][Full Text] [Related]
54. Simple 24-hour preservation of rabbit hearts with hexanol and pyruvate cardioplegia.
Kojima S; Wu ST; Wikman-Coffelt J; Parmley WW
J Mol Cell Cardiol; 1993 Apr; 25(4):453-8. PubMed ID: 8340934
[TBL] [Abstract][Full Text] [Related]
55. Assessment of ischemic injury and protective interventions: the Langendorff versus the working rat heart preparation.
Galinanes M; Hearse DJ
Can J Cardiol; 1990 Mar; 6(2):83-91. PubMed ID: 2310998
[TBL] [Abstract][Full Text] [Related]
56. Comparison of the solutions of Bretschneider, St. Thomas' Hospital and the National Institutes of Health for cardioplegic protection during moderate hypothermic arrest.
Kober IM; Obermayr RP; Brüll T; Ehsani N; Schneider B; Spieckermann PG
Eur Surg Res; 1998; 30(4):243-51. PubMed ID: 9704750
[TBL] [Abstract][Full Text] [Related]
57. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
[TBL] [Abstract][Full Text] [Related]
58. Role of sodium pump activity in warm induction of cardioplegia combined with reperfusion of oxygenated cardioplegic solution.
Ko T; Otani H; Imamura H; Omori K; Inagaki C
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):103-10. PubMed ID: 7609533
[TBL] [Abstract][Full Text] [Related]
59. Effect of cardioplegia infusion pressure on coronary artery endothelium and cardiac mechanical function.
Katayama O; Amrani M; Ledingham S; Jayakumar J; Smolenski RT; Severs N; Rothery S; Yacoub MH
Eur J Cardiothorac Surg; 1997 Apr; 11(4):751-62. PubMed ID: 9151049
[TBL] [Abstract][Full Text] [Related]
60. Protection of immature myocardium by the addition of mannitol to crystalloid cardioplegic solution.
Yang YJ
J Formos Med Assoc; 1991 Jan; 90(1):24-30. PubMed ID: 1679105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
